Background

HiQCell is a unique regenerative cell procedure for people with joint and tendon disease such as osteoarthritis and tendinopathy. The HiQCell procedure has been developed by Regeneus scientists and uses regenerative cells from a person's own adipose (fat) tissue to treat their condition.

Stem cells are a type of regenerative cell and form part of the body's own repair mechanisms. They are found throughout the body and when a stem cell divides, each new cell has the potential to either remain a stem cell or differentiate (change) into a specific cell type with a specialised function, such as a muscle cell, a red blood cell or a nerve cell.

Stem cells can be grouped into two types: adult stem cells and embryonic stem cells. The HiQCell procedure uses adult stem cells from the adipose tissue of the body. Adipose tissue contains many regenerative cells and is one of the richest sources of one particular type of adult stem cell called Mesenchymal Stem Cells (MSC). The HiQCell procedure does not use embryonic stem cells.

The HiQCell procedure involves injecting a mixture of cells taken from the person's own adipose tissue into an affected joint or tendon. This mixture contains adult stem cells along with a number of other cell types. The injected cells help to repair and regenerate affected sites by replacing lost or damaged cells, reducing inflammation, improving the function of cells at the site and recruiting cells from other parts of the body to assist in these processes.